Cargando…
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas
SIMPLE SUMMARY: Tumor mutation burden (TMB) has shown promise as a biomarker for immune checkpoint blockade therapy in some cancers, but not consistently in gliomas. The goal of our study was to systematically investigate the association between TMB, expressed neoantigens, and the tumor immune micro...
Autores principales: | Yu, Guangyang, Pang, Ying, Merchant, Mythili, Kesserwan, Chimene, Gangalapudi, Vineela, Abdelmaksoud, Abdalla, Ranjan, Alice, Kim, Olga, Wei, Jun S., Chou, Hsien-Chao, Wen, Xinyu, Sindiri, Sivasish, Song, Young K., Xi, Liqiang, Kaplan, Rosandra N., Armstrong, Terri S., Gilbert, Mark R., Aldape, Kenneth, Khan, Javed, Wu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657099/ https://www.ncbi.nlm.nih.gov/pubmed/34885201 http://dx.doi.org/10.3390/cancers13236092 |
Ejemplares similares
-
Paired Expression Analysis of Tumor Cell Surface Antigens
por: Orentas, Rimas J., et al.
Publicado: (2017) -
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
por: Parikh, Anup Y., et al.
Publicado: (2023) -
Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
por: Orentas, Rimas J., et al.
Publicado: (2014) -
Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment
por: Koustas, Evangelos, et al.
Publicado: (2023) -
Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2
por: Merchant, Mythili, et al.
Publicado: (2022)